Yanqiao Zhang

11PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers.

|Jun 04, 2026
Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.

|Mar 04, 2026
Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Chang Liu, Jiarui Li, Dan Liu

|Jan 14, 2025
Impact of Psychological Factors on Survival in Metastatic Esophagogastric Cancer: Secondary Analysis of a Randomized Controlled Trial.

Lili Song, Ying Pang, Yi He

|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.

Changsong Qi, Panpan Zhang, Chang Liu

|Apr 16, 2020
Etoposide and cisplatin versus irinotecan and cisplatin as the first-line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study.

Panpan Zhang, Jie Li, Jian Li

Pageof 2

Frequent Collaborators

4 joint publications

Lin Shen

3 joint publications

Xiaotian Zhang

2 joint publications

Zhihao Lu

2 joint publications

Zhi Peng